Near-Infrared Fluorescence Imaging of Renal Cell Carcinoma with ASP5354 in a Mouse Model for Intraoperative Guidance

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jul 9

PMID 35806231

Authors

Katsunori Teranishi

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinoma is a prevalent disease associated with high morbidity and mortality rates. Partial nephrectomy is a first-line surgical option because it allows the preservation of renal function. Clear differentiation between normal and cancerous tissues is critical for increasing the negative margin rates. This study investigated the capability of the near-infrared (NIR) fluorescent imaging agent ASP5354 for in vivo fluorescence imaging of renal cell carcinoma. ASP5354 at a single dose of 12 nmol (0.037 mg)/kg body weight was intravenously administered to healthy and orthotopic renal cell carcinoma mice under anesthesia. NIR images of the abdominal cavity were obtained using a near-infrared fluorescence (NIRF) camera system. In addition, the cancerous kidneys were harvested, and the NIRF in their sections was measured using an NIRF microscope. Normal renal tissue emitted strong NIRF but the cancer tissue did not. The difference in NIRF intensity between the normal and cancer tissues clearly presented the boundary between the normal and cancer tissues in macro and micro NIRF imaging. ASP5354 can distinguish cancer tissue from normal tissue using NIRF. Thus, ASP5354 is a promising agent for renal cell carcinoma tissue imaging in partial nephrectomy for renal cell carcinoma patients.

Citing Articles

Ready vascular permeability of a near-infrared fluorescent agent ASP5354 for intraoperative ureteral identification enables imaging of carcinoma tissues.

Teranishi K Sci Rep. 2023; 13(1):9832.

PMID: 37330535 PMC: 10276870. DOI: 10.1038/s41598-023-37025-z.

Evaluation of the Utilization of Near-Infrared Fluorescent Contrast Agent ASP5354 for In Vivo Ureteral Identification in Renal Diseases Using Rat Models of Gentamicin-Induced Acute Kidney Injury.

Teranishi K Diagnostics (Basel). 2023; 13(10).

PMID: 37238307 PMC: 10217322. DOI: 10.3390/diagnostics13101823.

In vivo near-infrared fluorescence imaging of gastric cancer in an MKN-45 gastric cancer xenograft mouse model using intraoperative ureteral identification agent ASP5354.

Teranishi K Photochem Photobiol Sci. 2023; 22(7):1721-1729.

PMID: 37010695 DOI: 10.1007/s43630-023-00410-8.

Bio-Nanohybrid Gelatin/Quantum Dots for Cellular Imaging and Biosensing Applications.

Samal S, Soenen S, Puppi D, De Wael K, Pati S, De Smedt S Int J Mol Sci. 2022; 23(19).

PMID: 36233168 PMC: 9570018. DOI: 10.3390/ijms231911867.

References

Fushiki H, Yoshikawa T, Matsuda T, Sato T, Suwa A . Preclinical Development and Validation of ASP5354: A Near-Infrared Fluorescent Agent for Intraoperative Ureter Visualization. Mol Imaging Biol. 2021; 25(1):74-84. DOI: 10.1007/s11307-021-01613-0. View

Yang X, Shao C, Wang R, Chu C, Hu P, Master V . Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. J Urol. 2012; 189(2):702-710. PMC: 4120709. DOI: 10.1016/j.juro.2012.09.056. View

Tobis S, Knopf J, Silvers C, Marshall J, Cardin A, Wood R . Near infrared fluorescence imaging after intravenous indocyanine green: initial clinical experience with open partial nephrectomy for renal cortical tumors. Urology. 2012; 79(4):958-64. DOI: 10.1016/j.urology.2011.10.016. View

Weissleder R . A clearer vision for in vivo imaging. Nat Biotechnol. 2001; 19(4):316-7. DOI: 10.1038/86684. View

Kurahashi T, Iwatsuki K, Onishi T, Arai T, Teranishi K, Hirata H . Near-infrared indocyanine dye permits real-time characterization of both venous and lymphatic circulation. J Biomed Opt. 2016; 21(8):86009. DOI: 10.1117/1.JBO.21.8.086009. View

Reinhart M, Huntington C, Blair L, Heniford B, Augenstein V . Indocyanine Green: Historical Context, Current Applications, and Future Considerations. Surg Innov. 2015; 23(2):166-75. DOI: 10.1177/1553350615604053. View

Venigalla S, Wu G, Miyamoto H . The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: a clinicopathologic study of 433 cases. Clin Genitourin Cancer. 2013; 11(4):527-36. DOI: 10.1016/j.clgc.2013.05.003. View

Murase T, Takizawa M, Galitz L, Flach S, Murray V, Gufford B . Randomized, Double-Blind, Controlled Study to Evaluate Safety and Pharmacokinetics of Single Ascending Doses of ASP5354, an Investigational Imaging Product, in Healthy Adult Volunteers. Clin Pharmacol Drug Dev. 2021; 10(12):1460-1468. PMC: 9292347. DOI: 10.1002/cpdd.1013. View

Muselaers C, Stillebroer A, Rijpkema M, Franssen G, Oosterwijk E, Mulders P . Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab. J Nucl Med. 2014; 55(6):1035-40. DOI: 10.2967/jnumed.114.137356. View

10.

Simone G, Tuderti G, Anceschi U, Ferriero M, Costantini M, Minisola F . "Ride the Green Light": Indocyanine Green-marked Off-clamp Robotic Partial Nephrectomy for Totally Endophytic Renal Masses. Eur Urol. 2018; 75(6):1008-1014. DOI: 10.1016/j.eururo.2018.09.015. View

11.

Angell J, Khemees T, Abaza R . Optimization of near infrared fluorescence tumor localization during robotic partial nephrectomy. J Urol. 2013; 190(5):1668-73. DOI: 10.1016/j.juro.2013.04.072. View

12.

Guzzo T, Jiang J, Keating J, DeJesus E, Judy R, Nie S . Intraoperative Molecular Diagnostic Imaging Can Identify Renal Cell Carcinoma. J Urol. 2015; 195(3):748-55. DOI: 10.1016/j.juro.2015.09.093. View

13.

Manny T, Krane L, Hemal A . Indocyanine green cannot predict malignancy in partial nephrectomy: histopathologic correlation with fluorescence pattern in 100 patients. J Endourol. 2013; 27(7):918-21. PMC: 3704115. DOI: 10.1089/end.2012.0756. View

14.

Shum C, Bahler C, Low P, Ratliff T, Kheyfets S, Natarajan J . Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases. J Endourol Case Rep. 2016; 2(1):189-197. PMC: 5107661. DOI: 10.1089/cren.2016.0104. View

15.

Tobis S, Knopf J, Silvers C, Messing E, Yao J, Rashid H . Robot-assisted and laparoscopic partial nephrectomy with near infrared fluorescence imaging. J Endourol. 2012; 26(7):797-802. DOI: 10.1089/end.2011.0604. View

16.

Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T . Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009; 115(11):2491-504. DOI: 10.1002/cncr.24291. View

17.

Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M . A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol. 2009; 100(1):75-9. DOI: 10.1002/jso.21272. View

18.

Mitsui Y, Shiina H, Arichi N, Hiraoka T, Inoue S, Sumura M . Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy. Int Urol Nephrol. 2012; 44(3):753-9. DOI: 10.1007/s11255-011-0120-x. View

19.

Du B, Chong Y, Jiang X, Yu M, Lo U, Dang A . Hyperfluorescence Imaging of Kidney Cancer Enabled by Renal Secretion Pathway Dependent Efflux Transport. Angew Chem Int Ed Engl. 2020; 60(1):351-359. PMC: 8635778. DOI: 10.1002/anie.202010187. View

20.

An H, Hou D, Zheng R, Wang M, Zeng X, Xiao W . A Near-Infrared Peptide Probe with Tumor-Specific Excretion-Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma. ACS Nano. 2020; 14(1):927-936. DOI: 10.1021/acsnano.9b08209. View